This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (542) Innovations and Technology in Cancer Care (424) Artificial Intelligence (1385)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45872, first published .
Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial

Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial

Creating an Innovative Artificial Intelligence–Based Technology (TCRact) for Designing and Optimizing T Cell Receptors for Use in Cancer Immunotherapies: Protocol for an Observational Trial

Authors of this article:

Joanna Bujak1, 2 Author Orcid Image ;   Stanisław Kłęk3 Author Orcid Image ;   Martyna Balawejder1 Author Orcid Image ;   Aleksandra Kociniak1 Author Orcid Image ;   Kinga Wilkus1 Author Orcid Image ;   Rafał Szatanek1 Author Orcid Image ;   Zofia Orzeszko4 Author Orcid Image ;   Joanna Welanyk3 Author Orcid Image ;   Grzegorz Torbicz5 Author Orcid Image ;   Mateusz Jęckowski6 Author Orcid Image ;   Tomasz Kucharczyk7 Author Orcid Image ;   Łukasz Wohadlo8 Author Orcid Image ;   Maciej Borys5 Author Orcid Image ;   Honorata Stadnik9 Author Orcid Image ;   Michał Wysocki5 Author Orcid Image ;   Magdalena Kayser10 Author Orcid Image ;   Marta Ewa Słomka6 Author Orcid Image ;   Anna Kosmowska10 Author Orcid Image ;   Karolina Horbacka10 Author Orcid Image ;   Tomasz Gach11 Author Orcid Image ;   Beata Markowska11 Author Orcid Image ;   Tomasz Kowalczyk8 Author Orcid Image ;   Jacek Karoń10 Author Orcid Image ;   Marek Karczewski9 Author Orcid Image ;   Mirosław Szura11 Author Orcid Image ;   Anna Sanecka-Duin1 Author Orcid Image ;   Agnieszka Blum1 Author Orcid Image
Article Authors Cited by (7) Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.